Chemed insider plans sale of 223 shares via Form 144
Chemed Corporation insider Patrick P. Grace has filed to potentially sell capital stock under a Form 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chemed Corporation insider Patrick P. Grace has filed to potentially sell capital stock under a Form 144. The filing lists a planned sale of 223 shares of capital stock, with an aggregate market value of $119,258, to be sold through J.P. Morgan Securities LLC on or after July 31, 2026 on the NYSE.
The form also notes that during the prior three months, Grace sold 60 shares of capital stock on May 10, 2026 for total proceeds of $25,547. The securities relate to director compensation.
Key Figures
Key Terms
Form 144 regulatory
capital stock financial
director compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Chemed (CHE) insider Patrick P. Grace report in this Form 144?
Which broker is named for the Chemed (CHE) Form 144 stock sale?
How are the Chemed (CHE) securities characterized in this Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.